The other risk is that by the time it takes to get RC220 into the clinic, another drug has made it to market which makes Bisantrene redundant as CP... (FTO and AC still viable)
Google, "experimental cardio protection drugs for chemo" and thousands of articles/reports pop up.
eg - https://www.einsteinmed.edu/news/2281/experimental-drug-may-prevent-chemotherapy-drug-from-damaging-the-heart/
Cardioprotection thread, page-17
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |